- Filed
- May 5, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 52.89M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 52.54M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $542K |
| Capex | Q1 2026 · Mar 31, 2025 | $422K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $35.4M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$28.3M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $162.18M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $132.13M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $103.97M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $71.79M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $1.06B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $1.08B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $1.04B |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $1.03B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $1.55B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $1.55B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $4.64B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $4.54B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.35 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.10 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.35 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.10 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $46.32M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $38.49M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$18.28M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$5.48M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $10.25M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $13.69M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $56.46M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $51.92M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $345M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $300.91M |
| Revenue | Q1 2026 · Mar 31, 2026 | $401.46M |
| Revenue | Q1 2026 · Mar 31, 2025 | $352.83M |